Guangdong VTR Bio-Tech Co (SZSE:300381) Cash-to-Debt : 12.78 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Guangdong VTR Bio-Tech Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Guangdong VTR Bio-Tech Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 12.78.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Guangdong VTR Bio-Tech Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Guangdong VTR Bio-Tech Co's Cash-to-Debt or its related term are showing as below:

SZSE:300381' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.1 Med: 0.37 Max: No Debt
Current: 12.78

During the past 13 years, Guangdong VTR Bio-Tech Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.10. And the median was 0.37.

SZSE:300381's Cash-to-Debt is ranked better than
59.3% of 1538 companies
in the Biotechnology industry
Industry Median: 6.485 vs SZSE:300381: 12.78

Guangdong VTR Bio-Tech Co Cash-to-Debt Historical Data

The historical data trend for Guangdong VTR Bio-Tech Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Guangdong VTR Bio-Tech Co Cash-to-Debt Chart

Guangdong VTR Bio-Tech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.21

0.39

0.32

10.30

9.61

Guangdong VTR Bio-Tech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															9.84	13.67	12.96	9.61	12.78

Competitive Comparison of Guangdong VTR Bio-Tech Co's Cash-to-Debt

For the Biotechnology subindustry, Guangdong VTR Bio-Tech Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong VTR Bio-Tech Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong VTR Bio-Tech Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Guangdong VTR Bio-Tech Co's Cash-to-Debt falls into.

Guangdong VTR Bio-Tech Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Guangdong VTR Bio-Tech Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1232.858	/	(128.245	+	0)
	=	9.61

Guangdong VTR Bio-Tech Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1067.794	/	(83.553	+	0)
	=	12.78

Guangdong VTR Bio-Tech Co (SZSE:300381) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Guangdong VTR Bio-Tech Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Pingbei 1st Road, Nanping Science and Technology Industrial Park, Guangdong Province, Zhuhai, CHN, 519060

Website

http://www.yiduoli.com

Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.

Guangdong VTR Bio-Tech Co (SZSE:300381) Headlines

No Headlines